Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/179996
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Whitlock, Gary G. | - |
dc.contributor.author | Protopapas, Konstantinos | - |
dc.contributor.author | Bernardino, José I. | - |
dc.contributor.author | Imaz, Arkaitz | - |
dc.contributor.author | Curran, Adrian | - |
dc.contributor.author | Stingone, Christof | - |
dc.contributor.author | Shivasankar, Sivapatham | - |
dc.contributor.author | Edwards, Sarah | - |
dc.contributor.author | Herbert, Sophie | - |
dc.contributor.author | Thomas, Konstantinos | - |
dc.contributor.author | Mican, Rafael | - |
dc.contributor.author | Prieto, Paula | - |
dc.contributor.author | Garcia Pérez, Jorge Néstor | - |
dc.contributor.author | Andreoni, Massimo | - |
dc.contributor.author | Hill, Samantha | - |
dc.contributor.author | Okhai, Hajra | - |
dc.contributor.author | Stuart, David | - |
dc.contributor.author | Bourne, Adam | - |
dc.contributor.author | Conway, Katie | - |
dc.date.accessioned | 2021-09-13T10:34:04Z | - |
dc.date.available | 2021-09-13T10:34:04Z | - |
dc.date.issued | 2021-08-25 | - |
dc.identifier.issn | 1468-1293 | - |
dc.identifier.uri | http://hdl.handle.net/2445/179996 | - |
dc.description.abstract | Introduction: Chemsex in a European context is the use of any of the following drugs to facilitate sex: crystal methamphetamine, mephedrone and gamma-hydroxybutyrate (GHB)/gamma-butyrolactone (GBL) and, to a lesser extent, cocaine and ketamine. This study describes the prevalence of self-reported recreational drug use and chemsex in HIV-positive men who have sex with men (MSM) accessing HIV services in four countries. It also examines the problematic impacts and harms of chemsex and access to chemsex-related services. Methods: This is a cross-sectional multi-centre questionnaire study of HIV-positive MSM accessing nine HIV services in the UK, Spain, Greece and Italy. Results: In all, 1589 HIV-positive MSM attending HIV services in four countries completed the questionnaire. The median age of participants was 38 years (interquartile range: 32-46 years) and 1525 (96.0%) were taking antiretroviral therapy (ART). In the previous 12 months, 709 (44.6%) had used recreational drugs, 382 (24.0%) reported chemsex and 104 (6.5%) reported injection of chemsex-associated drugs ('slamsex'). Of the 382 engaging in chemsex, 155 (40.6%) reported unwanted side effects as a result of chemsex and 81 (21.2%) as a result of withdrawal from chemsex. The reported negative impacts from chemsex were on work (25.1%, 96), friends/family (24.3%, 93) and relationships (28.3%, 108). Fifty-seven (14.9%) accessed chemsex-related services in the past year, 38 of whom (67%) felt the service met their needs. Discussion: A quarter of participants self-reported chemsex in the past 12 months. There were high rates of harms from chemsex across all countries, including negative impacts on work, friends/family and relationships. Although a minority of those engaging in chemsex accessed support, most found this useful. | - |
dc.format.extent | 15 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Wiley | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1111/hiv.13160 | - |
dc.relation.ispartof | HIV Medicine, 2021 | - |
dc.relation.uri | https://doi.org/10.1111/hiv.13160 | - |
dc.rights | cc by-nc-nd (c) Whitlock, Gary G. et al, 2021 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | Persones seropositives | - |
dc.subject.classification | Drogues de disseny | - |
dc.subject.other | HIV-positive persons | - |
dc.subject.other | Designer drugs | - |
dc.title | Chems4EU: chemsex use and its impacts across four European countries in HIV‐positive men who have sex with men attending HIV services | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2021-09-10T12:05:50Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 34432363 | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hiv.13160.pdf | 167.79 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License